Lycium barbarum–Polygonatum cyrtonema composite jiaosu (LBPCJ) was prepared by sequential dual-species fermentation and evaluated in a mouse model of alcohol-induced liver injury. Following process optimization, a yeast-first sequential strategy with intermediate pasteurization was selected, comprising an initial Saccharomyces cerevisiae fermentation step, intermediate pasteurization, and a subsequent Lactiplantibacillus plantarum fermentation step. Fermentation reduced pH from 4.68 to 3.51 and increased total acidity from 61.06 to 135.39 g LA/L and total phenolic content from 3.01 to 9.39 mg GAE/mL. In vitro antioxidant-related activities were also higher after fermentation, with DPPH, ABTS, and •OH scavenging rates increasing by 39.90%, 29.78%, and 11.10%, respectively. In mice, LBPCJ administration was associated with lower liver index and serum aminotransferase levels, together with attenuated hepatic histopathological alterations, with the high-dose group (15 mL/kg BW) showing the clearest response. These changes were accompanied by higher hepatic SOD and GSH levels and lower MDA, TNF-α, IL-1β, and IL-6 levels. LBJ and PCJ also improved several measured indicators, while LBPCJ showed changes across multiple endpoints under the tested conditions. Overall, sequential fermentation markedly altered the physicochemical and antioxidant-related properties of LBPCJ, and LBPCJ administration improved multiple indicators related to alcohol-induced liver injury in mice, although the specific constituents and underlying mechanisms remain to be clarified.
Yang et al. (Mon,) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: